GO:0000398 | mRNA splicing, via spliceosome | 3.37e-06 | 3.29e-02 | 5.083 | 4 | 8 | 128 |
GO:0000812 | Swr1 complex | 1.58e-05 | 1.54e-01 | 8.276 | 2 | 2 | 7 |
GO:0071013 | catalytic step 2 spliceosome | 1.90e-05 | 1.85e-01 | 5.738 | 3 | 5 | 61 |
GO:0031011 | Ino80 complex | 2.11e-05 | 2.06e-01 | 8.083 | 2 | 2 | 8 |
GO:0016363 | nuclear matrix | 3.26e-05 | 3.18e-01 | 5.479 | 3 | 7 | 73 |
GO:0043968 | histone H2A acetylation | 3.39e-05 | 3.31e-01 | 7.762 | 2 | 2 | 10 |
GO:0035267 | NuA4 histone acetyltransferase complex | 4.96e-05 | 4.84e-01 | 7.499 | 2 | 3 | 12 |
GO:0003678 | DNA helicase activity | 1.15e-04 | 1.00e+00 | 6.914 | 2 | 3 | 18 |
GO:0071339 | MLL1 complex | 1.15e-04 | 1.00e+00 | 6.914 | 2 | 2 | 18 |
GO:0043967 | histone H4 acetylation | 1.73e-04 | 1.00e+00 | 6.624 | 2 | 2 | 22 |
GO:0016020 | membrane | 2.12e-04 | 1.00e+00 | 2.431 | 6 | 38 | 1207 |
GO:0008380 | RNA splicing | 3.69e-04 | 1.00e+00 | 4.302 | 3 | 7 | 165 |
GO:0040008 | regulation of growth | 4.95e-04 | 1.00e+00 | 5.874 | 2 | 2 | 37 |
GO:0032508 | DNA duplex unwinding | 5.22e-04 | 1.00e+00 | 5.836 | 2 | 5 | 38 |
GO:0005654 | nucleoplasm | 5.32e-04 | 1.00e+00 | 2.631 | 5 | 55 | 876 |
GO:0006281 | DNA repair | 6.78e-04 | 1.00e+00 | 4.003 | 3 | 19 | 203 |
GO:0032481 | positive regulation of type I interferon production | 8.33e-04 | 1.00e+00 | 5.499 | 2 | 5 | 48 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 8.68e-04 | 1.00e+00 | 5.469 | 2 | 3 | 49 |
GO:0006310 | DNA recombination | 9.04e-04 | 1.00e+00 | 5.440 | 2 | 6 | 50 |
GO:0004151 | dihydroorotase activity | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0005681 | spliceosomal complex | 1.09e-03 | 1.00e+00 | 5.302 | 2 | 2 | 55 |
GO:0006325 | chromatin organization | 1.77e-03 | 1.00e+00 | 4.954 | 2 | 3 | 70 |
GO:0030323 | respiratory tube development | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:0030529 | ribonucleoprotein complex | 2.41e-03 | 1.00e+00 | 4.726 | 2 | 4 | 82 |
GO:0005730 | nucleolus | 2.44e-03 | 1.00e+00 | 2.156 | 5 | 41 | 1217 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0042802 | identical protein binding | 3.37e-03 | 1.00e+00 | 3.201 | 3 | 7 | 354 |
GO:0016887 | ATPase activity | 3.57e-03 | 1.00e+00 | 4.440 | 2 | 6 | 100 |
GO:0051414 | response to cortisol | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0071169 | establishment of protein localization to chromatin | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0014075 | response to amine | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0003924 | GTPase activity | 5.01e-03 | 1.00e+00 | 4.189 | 2 | 3 | 119 |
GO:0001055 | RNA polymerase II activity | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0006184 | GTP catabolic process | 5.96e-03 | 1.00e+00 | 4.061 | 2 | 3 | 130 |
GO:0005524 | ATP binding | 5.99e-03 | 1.00e+00 | 2.283 | 4 | 23 | 892 |
GO:0090073 | positive regulation of protein homodimerization activity | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 7 |
GO:0031122 | cytoplasmic microtubule organization | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 2 | 8 |
GO:0005634 | nucleus | 8.11e-03 | 1.00e+00 | 1.226 | 7 | 67 | 3246 |
GO:0031996 | thioesterase binding | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 9 |
GO:0032479 | regulation of type I interferon production | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 2 | 9 |
GO:0008266 | poly(U) RNA binding | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 10 |
GO:0006541 | glutamine metabolic process | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 10 |
GO:0035458 | cellular response to interferon-beta | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 10 |
GO:0001054 | RNA polymerase I activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 10 |
GO:0007020 | microtubule nucleation | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0010467 | gene expression | 1.07e-02 | 1.00e+00 | 2.605 | 3 | 31 | 535 |
GO:0071392 | cellular response to estradiol stimulus | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 13 |
GO:0001056 | RNA polymerase III activity | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 13 |
GO:0035066 | positive regulation of histone acetylation | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 14 |
GO:0050699 | WW domain binding | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 14 |
GO:0005525 | GTP binding | 1.33e-02 | 1.00e+00 | 3.461 | 2 | 5 | 197 |
GO:0005829 | cytosol | 1.34e-02 | 1.00e+00 | 1.602 | 5 | 58 | 1787 |
GO:0007250 | activation of NF-kappaB-inducing kinase activity | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 16 |
GO:0005719 | nuclear euchromatin | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 16 |
GO:0043234 | protein complex | 1.50e-02 | 1.00e+00 | 3.369 | 2 | 8 | 210 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 2 | 17 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 18 |
GO:0033574 | response to testosterone | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 18 |
GO:0000794 | condensed nuclear chromosome | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 3 | 18 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 20 |
GO:0017144 | drug metabolic process | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 21 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 24 |
GO:0005164 | tumor necrosis factor receptor binding | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 24 |
GO:0004003 | ATP-dependent DNA helicase activity | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 2 | 25 |
GO:0007585 | respiratory gaseous exchange | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.46e-02 | 1.00e+00 | 5.329 | 1 | 2 | 27 |
GO:0008270 | zinc ion binding | 2.46e-02 | 1.00e+00 | 2.163 | 3 | 7 | 727 |
GO:0034644 | cellular response to UV | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 28 |
GO:0018107 | peptidyl-threonine phosphorylation | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 2 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.64e-02 | 1.00e+00 | 5.225 | 1 | 2 | 29 |
GO:0043195 | terminal bouton | 2.82e-02 | 1.00e+00 | 5.129 | 1 | 1 | 31 |
GO:0031490 | chromatin DNA binding | 2.82e-02 | 1.00e+00 | 5.129 | 1 | 1 | 31 |
GO:0015030 | Cajal body | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 32 |
GO:0007595 | lactation | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 2 | 32 |
GO:0046330 | positive regulation of JNK cascade | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 1 | 34 |
GO:0044822 | poly(A) RNA binding | 3.15e-02 | 1.00e+00 | 2.026 | 3 | 25 | 799 |
GO:0050434 | positive regulation of viral transcription | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 2 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 36 |
GO:0045860 | positive regulation of protein kinase activity | 3.36e-02 | 1.00e+00 | 4.874 | 1 | 1 | 37 |
GO:0005515 | protein binding | 3.44e-02 | 1.00e+00 | 0.881 | 7 | 76 | 4124 |
GO:0035690 | cellular response to drug | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 38 |
GO:0006396 | RNA processing | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 6 | 40 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 40 |
GO:0042995 | cell projection | 3.72e-02 | 1.00e+00 | 4.726 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 3.72e-02 | 1.00e+00 | 4.726 | 1 | 9 | 41 |
GO:0004386 | helicase activity | 3.81e-02 | 1.00e+00 | 4.691 | 1 | 2 | 42 |
GO:0031100 | organ regeneration | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 2 | 44 |
GO:0006334 | nucleosome assembly | 4.61e-02 | 1.00e+00 | 4.411 | 1 | 4 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.61e-02 | 1.00e+00 | 4.411 | 1 | 5 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 3 | 52 |
GO:0006289 | nucleotide-excision repair | 4.78e-02 | 1.00e+00 | 4.356 | 1 | 9 | 53 |
GO:0003677 | DNA binding | 4.89e-02 | 1.00e+00 | 1.781 | 3 | 18 | 947 |
GO:0070062 | extracellular vesicular exosome | 4.92e-02 | 1.00e+00 | 1.403 | 4 | 43 | 1641 |
GO:0006338 | chromatin remodeling | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 2 | 55 |
GO:0006915 | apoptotic process | 5.23e-02 | 1.00e+00 | 2.400 | 2 | 21 | 411 |
GO:0007565 | female pregnancy | 5.75e-02 | 1.00e+00 | 4.083 | 1 | 2 | 64 |
GO:0005923 | tight junction | 5.75e-02 | 1.00e+00 | 4.083 | 1 | 2 | 64 |
GO:0005200 | structural constituent of cytoskeleton | 6.10e-02 | 1.00e+00 | 3.996 | 1 | 2 | 68 |
GO:0045087 | innate immune response | 6.20e-02 | 1.00e+00 | 2.263 | 2 | 7 | 452 |
GO:0051082 | unfolded protein binding | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 4 | 70 |
GO:0001889 | liver development | 6.36e-02 | 1.00e+00 | 3.934 | 1 | 1 | 71 |
GO:0005737 | cytoplasm | 6.58e-02 | 1.00e+00 | 1.043 | 5 | 50 | 2633 |
GO:0001649 | osteoblast differentiation | 6.62e-02 | 1.00e+00 | 3.874 | 1 | 2 | 74 |
GO:0005815 | microtubule organizing center | 6.88e-02 | 1.00e+00 | 3.817 | 1 | 1 | 77 |
GO:0051607 | defense response to virus | 8.17e-02 | 1.00e+00 | 3.560 | 1 | 1 | 92 |
GO:0000086 | G2/M transition of mitotic cell cycle | 8.60e-02 | 1.00e+00 | 3.484 | 1 | 5 | 97 |
GO:0006457 | protein folding | 8.60e-02 | 1.00e+00 | 3.484 | 1 | 4 | 97 |
GO:0007507 | heart development | 9.36e-02 | 1.00e+00 | 3.356 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 9.36e-02 | 1.00e+00 | 3.356 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 9.61e-02 | 1.00e+00 | 3.315 | 1 | 3 | 109 |
GO:0006397 | mRNA processing | 9.70e-02 | 1.00e+00 | 3.302 | 1 | 2 | 110 |
GO:0042981 | regulation of apoptotic process | 9.87e-02 | 1.00e+00 | 3.276 | 1 | 18 | 112 |
GO:0016607 | nuclear speck | 1.07e-01 | 1.00e+00 | 3.153 | 1 | 3 | 122 |
GO:0004672 | protein kinase activity | 1.10e-01 | 1.00e+00 | 3.118 | 1 | 2 | 125 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.15e-01 | 1.00e+00 | 1.753 | 2 | 8 | 644 |
GO:0031625 | ubiquitin protein ligase binding | 1.20e-01 | 1.00e+00 | 2.975 | 1 | 5 | 138 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.24e-01 | 1.00e+00 | 2.934 | 1 | 2 | 142 |
GO:0005622 | intracellular | 1.26e-01 | 1.00e+00 | 2.904 | 1 | 1 | 145 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.39e-01 | 1.00e+00 | 2.753 | 1 | 4 | 161 |
GO:0007067 | mitotic nuclear division | 1.42e-01 | 1.00e+00 | 2.717 | 1 | 8 | 165 |
GO:0007283 | spermatogenesis | 1.45e-01 | 1.00e+00 | 2.691 | 1 | 2 | 168 |
GO:0043025 | neuronal cell body | 1.47e-01 | 1.00e+00 | 2.666 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 1.51e-01 | 1.00e+00 | 2.624 | 1 | 6 | 176 |
GO:0004842 | ubiquitin-protein transferase activity | 1.53e-01 | 1.00e+00 | 2.600 | 1 | 2 | 179 |
GO:0016567 | protein ubiquitination | 1.61e-01 | 1.00e+00 | 2.529 | 1 | 3 | 188 |
GO:0005856 | cytoskeleton | 1.62e-01 | 1.00e+00 | 2.514 | 1 | 2 | 190 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.72e-01 | 1.00e+00 | 2.418 | 1 | 1 | 203 |
GO:0019899 | enzyme binding | 1.78e-01 | 1.00e+00 | 2.369 | 1 | 4 | 210 |
GO:0007275 | multicellular organismal development | 1.81e-01 | 1.00e+00 | 2.342 | 1 | 4 | 214 |
GO:0005813 | centrosome | 1.83e-01 | 1.00e+00 | 2.322 | 1 | 8 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 1.84e-01 | 1.00e+00 | 2.315 | 1 | 7 | 218 |
GO:0006200 | ATP catabolic process | 1.85e-01 | 1.00e+00 | 2.309 | 1 | 8 | 219 |
GO:0019901 | protein kinase binding | 1.95e-01 | 1.00e+00 | 2.225 | 1 | 11 | 232 |
GO:0003723 | RNA binding | 2.06e-01 | 1.00e+00 | 2.135 | 1 | 11 | 247 |
GO:0000278 | mitotic cell cycle | 2.55e-01 | 1.00e+00 | 1.789 | 1 | 35 | 314 |
GO:0006351 | transcription, DNA-templated | 2.61e-01 | 1.00e+00 | 1.012 | 2 | 9 | 1076 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.74e-01 | 1.00e+00 | 1.670 | 1 | 6 | 341 |
GO:0048471 | perinuclear region of cytoplasm | 2.76e-01 | 1.00e+00 | 1.657 | 1 | 5 | 344 |
GO:0005783 | endoplasmic reticulum | 3.01e-01 | 1.00e+00 | 1.510 | 1 | 3 | 381 |
GO:0005794 | Golgi apparatus | 3.24e-01 | 1.00e+00 | 1.387 | 1 | 5 | 415 |
GO:0016032 | viral process | 3.32e-01 | 1.00e+00 | 1.342 | 1 | 32 | 428 |
GO:0007165 | signal transduction | 4.45e-01 | 1.00e+00 | 0.812 | 1 | 5 | 618 |
GO:0044281 | small molecule metabolic process | 5.57e-01 | 1.00e+00 | 0.362 | 1 | 32 | 844 |
GO:0005886 | plasma membrane | 8.37e-01 | 1.00e+00 | -0.717 | 1 | 11 | 1784 |